Provided by Tiger Trade Technology Pte. Ltd.

Zentalis Pharmaceuticals, LLC

3.77
+0.06001.62%
Post-market: 3.770.00000.00%16:10 EDT
Volume:897.77K
Turnover:3.39M
Market Cap:356.91M
PE:-1.92
High:3.88
Open:3.68
Low:3.68
Close:3.71
52wk High:6.95
52wk Low:1.21
Shares:94.67M
Float Shares:75.29M
Volume Ratio:1.48
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9591
EPS(LYR):-1.9100
ROE:-66.75%
ROA:-33.15%
PB:2.48
PE(LYR):-1.97

Loading ...

Jun 06, 2023

Major Issues Report

Form 8-K - Current report
May 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 27, 2023

Major Issues Report

Form 8-K - Current report
May 10, 2023

Major Issues Report

8-K - Current report
May 10, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 26, 2023

Major Issues Report

8-K - Current report
Apr 17, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 09, 2023

Major Issues Report

8-K - Current report
Mar 01, 2023

Major Issues Report

8-K - Current report
Mar 01, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Major Issues Report

8-K - Current report
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report